SCHEMBL357196

SCHEMBL357196

O=S(=O)(O)C(F)(F)C(F)OC(F)(F)C(F)(F)F

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2047142 0.98
SCHEMBL4965422 0.88
SCHEMBL3646926 0.82 CES1 (0.33)
SCHEMBL647908 0.82 ALDH1A1 (0.32) ALDH1A1L3MBTL1
SCHEMBL357060 0.80 ALDH1A1 (0.31) ALDH1A1L3MBTL1
Phosphine SCHEMBL4090593 0.80 ALDH1A1 (0.31) ALDH1A1L3MBTL1
SCHEMBL13049523 0.80
SCHEMBL3394318 0.79 CES1 (0.33)
SCHEMBL4367948 0.78
Potassium Ion SCHEMBL357913 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150082981-A1 CAPTURE OF TRIFLUOROMETHANE USING IONIC LIQUIDS E I DU PONT DE NEMOURS AND COMPANY (US) 2015-03-26 US claimed
US-8779220-B2 Capture of fluorinated vinyl monomers using ionic liquids E I DU PONT DE NEMOURS AND COMPANY (US) 2014-07-15 US claimed
US-20130267668-A1 POLYMERIZATION OF FLUORINATED VINYL MONOMERS IN A BIPHASIC REACTION MEDIUM E I DU PONT DE NEMOURS AND COMPANY (US) 2013-10-10 US claimed
EP-2021276-B1 PROCESS FOR PURIFYING PERFLUORINATED PRODUCTS DU PONT (US) 2013-07-17 EP claimed
WO-2013090941-A1 POLYMERIZATION OF FLUORINATED VINYL MONOMERS IN AQUEOUS SALT SOLUTIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2013-06-20 WO claimed
US-20130149596-A1 ELECTROLYTE SOLVENT CONTAINING IONIC LIQUIDS E.I DU PONT DE NEMOURS AND COMPANY (US) 2013-06-13 US claimed
US-20130123448-A1 CAPTURE OF FLUORINATED VINYL MONOMERS USING IONIC LIQUIDS E I DU PONT DE NEMOURS AND COMPANY (US) 2013-05-16 US claimed
EP-1954680-B1 IONIC LIQUIDS DU PONT (US) 2012-05-23 EP claimed
US-20110195212-A1 Flame Retardant Polycarbonate Compositions E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-08-11 US claimed
US-7838684-B2 Fluorinated anions; cation selected from pyridinium, pyridazinium, pyrimidinium, pyrazinium, imidazolium, pyrazolium, thiazolium, oxazolium, triazolium, and phosphonium, ammonium cations with specified substituents, and anion is fluorinated sulfonium, sulfonylimide E.I. DU PONT DE NEMOURS AND COMPANY (US) 2010-11-23 US claimed
US-20090227447-A1 Ionic Liquids E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-09-10 US claimed
US-7544813-B2 Ionic liquids E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-06-09 US claimed
EP-1940914-B1 PREPARATION OF POLYTRIMETHYLENE ETHER GLYCOL AND COPOLYMERS THEREOF DU PONT (US) 2009-05-13 EP claimed
US-20080221241-A1 Flame Retardant Polycarbonate Compositions E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-09-11 US claimed
US-20070100181-A1 Olefin isomerization E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US claimed
US-20070100183-A1 Alkylation of aromatic compounds E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US claimed
US-20070098619-A1 Porous microcomposite of fluorinated sulfonic acid and a network of silica E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US claimed
US-20070100193-A1 Olefin polymerization E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US claimed
US-20070100192-A1 Olefin isomerization E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US claimed
US-20070066822-A1 Ionic liquids THE CHEMOURS COMPANY FC, LLC 2007-03-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070100192-A1 Olefin isomerization OSBP, OXER1, OSBPL3 ALDH1A1 638/4885L3MBTL1 759/4885
US-20070100181-A1 Olefin isomerization OSBP, OXER1, ALOX12 ALDH1A1 685/4885L3MBTL1 1110/4885
US-20130123448-A1 CAPTURE OF FLUORINATED VINYL MONOMERS USING IONIC LIQUIDS VCL, MFAP1, VAV1 ALDH1A1 1316/4885L3MBTL1 666/4885
US-20070066822-A1 Ionic liquids AFF2, AFF1, ZYX ALDH1A1 3728/4885L3MBTL1 857/4885
US-20070100183-A1 Alkylation of aromatic compounds NUTF2, AHR, TRPA1 ALDH1A1 1832/4885L3MBTL1 3259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.